R. W. Williams
#158,611
Most Influential Person Now
R. W. Williams's AcademicInfluence.com Rankings
R. W. Williamsphilosophy Degrees
Philosophy
#9056
World Rank
#12554
Historical Rank
Logic
#6056
World Rank
#7536
Historical Rank

Download Badge
Philosophy
R. W. Williams's Degrees
- Doctorate Medicine Harvard University
Why Is R. W. Williams Influential?
(Suggest an Edit or Addition)R. W. Williams's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Acute liver failure: redefining the syndromes (1993) (877)
- Pilot‐controlled trial of the extracorporeal liver assist device in acute liver failure (1996) (516)
- Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. (1988) (515)
- Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. (1991) (510)
- Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. (1992) (336)
- Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. (1982) (272)
- Plasma and Brain Amino Acids in Fulminant Hepatic Failure and their Relationship to Hepatic Encephalopathy (1976) (270)
- Wilson's disease: clinical presentation and use of prognostic index. (1986) (232)
- Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases (1998) (205)
- Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. (1975) (186)
- Classification, etiology, and considerations of outcome in acute liver failure. (1996) (169)
- Maternal and perinatal outcome in severe pregnancy‐related liver disease (1997) (162)
- Hepatic encephalopathy and cerebral edema. (1986) (161)
- Tumour necrosis factor α is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis (2003) (156)
- Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. (1986) (153)
- Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. (1991) (141)
- PLASMA AND BRAIN TRYPTOPHAN CHANGES IN EXPERIMENTAL ACUTE HEPATIC FAILURE (1973) (125)
- Earlier identification of patients at risk from acetaminophen-induced acute liver failure. (1998) (123)
- Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. (1986) (121)
- Tissue hypoxia during fulminant hepatic failure (1985) (116)
- Remote ischaemic preconditioning of the hind limb reduces experimental liver warm ischaemia–reperfusion injury (2006) (112)
- Lactic acidosis in fulminant hepatic failure. Some aspects of pathogenesis and prognosis. (1985) (107)
- Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure (1994) (103)
- Acid-base and metabolic disturbances in fulminant hepatic failure. (1975) (103)
- Reticuloendothelial system and hepatocytic function in fulminant hepatic failure. (1982) (102)
- Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. (1995) (101)
- Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study. (1998) (100)
- Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome. (1993) (100)
- Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure (1996) (97)
- The safety and value of extradural intracranial pressure monitors in fulminant hepatic failure. (1993) (96)
- Intravascular coagulation in acute hepatic necrosis. (1970) (94)
- Clinical monitoring of intracranial pressure in fulminant hepatic failure. (1980) (89)
- N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. (1997) (86)
- Early and intensive therapy of intravascular coagulation in acute liver failure. (1971) (86)
- Metabolism of cysteinyl leukotrienes in monkey and man. (1990) (85)
- Pathophysiology of hypotension in patients with fulminant hepatic failure. (1977) (81)
- Fulminant hepatic failure in childhood (1980) (81)
- PROSPECTS FOR EXTRACORPOREAL LIVER SUPPORT (2004) (81)
- Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. (2004) (80)
- Anti-tuberculous therapy and acute liver failure (1995) (77)
- Fulminant hepatic failure secondary to hydroxychloroquine. (1994) (76)
- Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure (1996) (73)
- High resolution proton nuclear magnetic resonance studies of human cerebrospinal fluid. (1987) (69)
- Bacteraemia in patients with fulminant hepatic failure. (2008) (68)
- Use of bioartificial and artificial liver support devices. (1996) (66)
- Metabolic profiling of body fluids by proton NMR: Self‐poisoning episodes with paracetamol (acetaminophen) (1988) (66)
- Increased production of cysteinyl leukotrienes in hepatorenal syndrome. (1990) (60)
- Experiences in the treatment of fulminant hepatic failure by conservative therapy, charcoal haemoperfusion, and polyacrylonitrile haemodialysis. (1978) (59)
- Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. (1991) (58)
- The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. (1976) (56)
- Frequency of arrhythmias and other cardiac abnormalities in fulminant hepatic failure. (1976) (54)
- Extent of the acute phase response in fulminant hepatic failure. (1994) (53)
- Regional cerebral edema and chloride space in galactosamine‐induced liver failure in rats (1997) (53)
- Review article: the Molecular Adsorbents Recirculating System (MARS) in liver failure (2002) (52)
- Effect of prostacyclin (PGI2) and a prostaglandin analogue BW 245C on galactosamine-induced hepatic necrosis. (1986) (50)
- Temporary Extracorporeal Liver Support for Severe Acute Alcoholic Hepatitis Using the Biologic-DT (1999) (50)
- Temporary Extracorporeal Liver Support for Severe Acute Alcoholic Hepatitis Using the Biologic-Dt (1998) (49)
- Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure. (1998) (48)
- Effects of Serial Resin Hemoperfusion in Fulminant Hepatic Failure (1983) (47)
- A prospective reappraisal of emergency endoscopy in patients with portal hypertension. (1982) (45)
- The inflammatory basis of intracranial hypertension in acute liver failure. (2001) (45)
- Frequency of pancreatitis in fulminant hepatic failure using isoenzyme markers. (1988) (44)
- Fibronectin in fulminant hepatic failure. (1982) (44)
- Serum, cerebrospinal fluid, and brain levels of bile acids in patients with fulminant hepatic failure. (1977) (41)
- Albumin-coated Amberlite XAD-7 resin for hemoperfusion in acute liver failure. Part II: in vivo evaluation. (1979) (40)
- Factors contributing to mortality in paracetamol-induced hepatic failure. (1981) (38)
- Neutrophil adherence in chronic liver disease and fulminant hepatic failure. (1983) (37)
- Prognostic value of serum alpha-fetoprotein in fulminant hepatic failure including patients treated by charcoal haemoperfusion. (1976) (37)
- Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure. (1990) (36)
- Liver Transplantation in Man—IV, Haemorrhage and Thrombosis (1969) (35)
- Albumin-coated Amberlite XAD-7 resin for hemoperfusion in acute liver failure. Part I: adsorption studies. (1979) (35)
- Spontaneous bacterial peritonitis. (1985) (35)
- In vitro plasma perfusion through adsorbents and plasma ultrafiltration to remove endotoxin and cytokines. (1992) (34)
- The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy. (1995) (33)
- Systemic and hepatic hemodynamic changes in acute liver injury. (1997) (33)
- Coagulation abnormalities in acute liver failure; pathogenetic and therapeutic implications. (1973) (32)
- A dog model of fulminant hepatic failure produced by paracetamol administration. (1975) (32)
- Glutathione S-transferase levels in autoimmune chronic active hepatitis: a more sensitive index of hepatocellular damage than aspartate transaminase. (1988) (32)
- Biochemical mechanisms of hepatic encephalopathy. (1983) (31)
- Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure. (1994) (31)
- A model to study total hepatic ischemia-reperfusion injury. (2004) (30)
- Controlled trial of antithrombin III supplementation in fulminant hepatic failure. (1993) (30)
- Plasma short-chain fatty acids in fulminant hepatic failure. (1977) (29)
- Neurological sequelae in patients recovered from fulminant hepatic failure. (1987) (29)
- Prospective comparison of two Sengstaken tubes in the management of patients with variceal haemorrhage. (1980) (29)
- Disorderd hemostasis in liver damage from paracetamol overdose. (1973) (29)
- Progress in the treatment of chronic portasystemic encephalopathy. (1984) (28)
- Fulminant hepatic failure. (2000) (28)
- Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure. (1982) (28)
- 75Se-selenomethionine in the scintiscan diagnosis of primary hepatocellular carcinoma (1971) (27)
- Budd-Chiari syndrome presenting as fulminant hepatic failure. (1986) (27)
- Use of sorbent columns and haemofiltration in fulminant hepatic failure. (1993) (27)
- Late-onset hepatic failure: clinical features, serology and outcome following transplantation. (1995) (27)
- Platelet adhesiveness to glass beads in liver disease. (1982) (26)
- Metal ions catalytic for free radical reactions in the plasma of patients with fulminant hepatic failure. (1994) (25)
- Induction and role of NO synthase in hypotensive hepatic failure. (1997) (25)
- Intravascular coagulation in acute hepatic necrosis. (1970) (25)
- Effects of cerebral oedema and arterial hypotension on cerebral blood flow in an animal model of hepatic failure (1978) (24)
- Renal function in fulminant hepatic failure: haemodynamics and renal prostaglandins. (1987) (24)
- Subacute hepatic necrosis induced by piroxicam. (1986) (24)
- Circulating lysosomal enzymes and acute hepatic necrosis. (1981) (24)
- Hepatotoxicity of antituberculosis drugs. (1996) (24)
- Natural history of acute decompensation of cirrhosis: The basis of the definition, prognosis and pathophysiology of acute on chronic liver failure (2006) (24)
- Potential toxins of acute liver failure and their effects on blood-brain barrier permeability (1983) (23)
- Experimental hepatic necrosis: Studies on coagulation abnormalities, plasma clearance, and organ distribution of 125I-labelled fibrinogen (1973) (23)
- Reduced brain Na+, K+-ATPase activity in rats with galactosamine-induced hepatic failure: relationship to encephalopathy and cerebral oedema. (1987) (22)
- Effect of ELAD Liver Support on Plasma HGF and TGF–β1 in Acute Liver Failure (1996) (22)
- Acquired Dysfibrinogenemia in Acute and Chronic Liver Disease (1977) (21)
- Halothane-induced acute liver failure: continuing occurrence and use of liver transplantation. (1998) (21)
- Synthesis and metabolism of cysteinyl leukotrienes by the isolated pig kidney. (1992) (21)
- Fibrinogen derivatives and platelet activation products in acute and chronic liver disease. (1985) (20)
- Determination of the ketone body ratio in fulminant hepatic failure. (1990) (19)
- Effects of converting enzyme inhibitor on hepatic blood flow in man. (1984) (19)
- Inhibition of partially purified rat brain Na+, K+-dependent ATPase by bile acids, phenolic acids and endotoxin. (1984) (19)
- Assessment of Bioartificial Liver Support in Acute Liver Failure (1996) (18)
- Artificial liver support in acute liver failure: a review of studies at King's. (2008) (18)
- Polymorph leucocyte function in uraemia and jaundice. (1980) (17)
- Management of liver failure. (1986) (17)
- Plasma inhibitory activity against tumour necrosis factor in fulminant hepatic failure. (1996) (17)
- Adsorption of human serum albumin to Amberlite XAD-7 resin. (1979) (16)
- Primary sepsis presenting as fulminant hepatic failure. (1989) (15)
- The use of prostacyclin, PGI2, in the prevention of platelet aggregation during charcoal haemoperfusion. (1979) (15)
- Physiological inhibitors of coagulation in fulminant hepatic failure (1992) (15)
- Evaluation of extracorporeal bioartificial liver devices. (1995) (14)
- Anoxic hepatic and intestinal injury from carbon monoxide poisoning. (1984) (14)
- Depressed uptake of serotonin by platelets in hepatic encephalopathy. (1980) (14)
- Increased elastase-alpha 1-antitrypsin complex in fulminant hepatic failure: relationship to bacterial infection and activation of coagulation. (1991) (13)
- Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure. (1997) (13)
- Protective effects of propylene glycol, a solvent used pharmaceutically, against paracetamol-induced liver injury in mice. (1991) (12)
- The diagnosis of primary malignant tumours of the liver. Findings in 48 consecutive patients. (1972) (12)
- Removal of inhibitors of brain Na+, K+-ATPase by hemoperfusion in fulminant hepatic failure. (1984) (11)
- Myocarditis and fulminant hepatic failure from coxsackievirus B infection. (1985) (11)
- Plasma amino acids in experimental acute hepatic failure and their relationship to brain tryptophan. (1974) (11)
- Prognostic value of the oculovestibular reflex in fulminant hepatic failure. (1978) (11)
- The use of an in vitro haemoperfusion circuit to evaluate the blood compatibility of albumin-coated Amberlite XAD-7 resin. (1978) (10)
- Liver scintiscanning in acute hepatic necrosis. (1971) (10)
- In-Vitro Blood Compatibility Studies on a New Polymer-Coated Charcoal for Haemoperfusion (1980) (10)
- Glycerol therapy for cerebral oedema complicating fulminant hepatic failure. (1975) (9)
- Antithrombin III Infusion During Fulminant Hepatic Failure (1981) (9)
- Wilson's disease: a diagnostic dilemma. (1983) (9)
- Clearance and tissue distribution of staphylococcal enterotoxin A in the rat and potential use of adsorbents for removal from plasma. (1993) (9)
- Treatment of fulminant hepatic failure. Clinical syndrome and basis of therapy. (1971) (9)
- Synthesis and metabolism of cysteinyl leukotrienes by the isolated pig kidney. (1992) (8)
- In vivo and in vitro studies on the protective effects of 9 beta-methylcarbacyclin, a stable prostacyclin analogue, in galactosamine-induced hepatocellular damage. (1990) (8)
- Thermal desorption-gas chromatography of plasma isovaleraldehyde in hepatic encephalopathy in man. (1987) (8)
- Continuous bipolar recording of the EEG in patients with fulminant hepatic failure. (1978) (8)
- Effect of supernatants from Kupffer cells stimulated with galactosamine and endotoxin on the function of isolated rat hepatocytes. (1993) (7)
- Metabolic effects of beta-adrenergic receptor blockade in advanced alcoholic cirrhosis. (1993) (7)
- Fibrinolytic abnormalities following liver transplantation in patients with fulminant hepatic failure. (1995) (7)
- Neutrophil Adherence during Hemoperfusion in Fulminant Hepatic Failure (1982) (7)
- Artificial liver support: Overview of Registry and controlled clinical trials (2003) (7)
- Sodium handling in the isolated perfused kidney of the cirrhotic rat. (1989) (7)
- Affinity chromatography systems for artificial liver support. (1977) (7)
- Platelet function during haemoperfusion in acute liver failure (1980) (6)
- Progress in the management of fulminant hepatic failure (1981) (6)
- Raised serum biliverdin in hepatic necrosis. (1981) (6)
- MARS: a new treatment for hepatorenal failure. Molecular adsorbent and recirculating system. (2000) (6)
- FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure (1994) (6)
- Physico-chemical aspects of the removal of protein-bound substances by charcoal and other adsorbents of potential value in systems of artificial liver support: Part 1—Equilibrium properties (1978) (6)
- Mars in decompensated alcoholic liver disease with multi-organ failure. (2001) (6)
- Artificial liver support in fulminant hepatic failure. (1975) (5)
- The effect of prostaglandin E1 and adenosine on adverse platelet reactions during charcoal haemoperfusion. (1978) (5)
- TREATMENT WITH INFLIXIMAB INCREASES E-NOS ACTIVITY IN CIRRHOSIS THROUGH MODULATION OF THE DDAH-ADMA PATHWAY (2009) (5)
- A circulating inhibitor of leucocyte sodium transport in patients with advanced liver cirrhosis. (1984) (5)
- Physico-chemical aspects of the removal of protein-bound substances by charcoal and other adsorbents of potential value in systems of artificial liver support: Part 2—Kinetics of removal (1978) (4)
- Proceedings: Defective platelet function with deficiency of 'sticky platelets' in fulminant hepatic failure. (1975) (4)
- Liver disease in childhood: principles of management. (1974) (4)
- Pulmonary complications in fulminant hepatic failure: analysis of serial radiographs from 100 consecutive patients. (1978) (4)
- A Review of Mediators and the Hepatorenal Syndrome (1990) (3)
- Protein synthesis by the liver after transplantation. (1970) (3)
- Intravascular coagulation in acute hepatic necrosis: clinical and experimental studies into the deposition of microthrombi and the effect of treatment. (1971) (3)
- Studies on plasma cytotoxicity and liver regeneration in fulminant hepatic failure. (1977) (3)
- Intravascular coagulation in acute hepatic failure. (1970) (3)
- Splanchnic ischemia is associated with increased intestinal permeability, endotoxemia and bacteremia in general intensive care patients but not in acute liver failure (1998) (3)
- Use of artificial liver support. (1985) (3)
- Plasma prostaglandins in fulminant hepatic failure. (1975) (3)
- Use of prostacyclin in extracorporeal circulation. (1985) (3)
- Diagnosis and prognosis of primary malignant tumors of the liver. (1970) (3)
- Histological appearances in fulminant hepatic failure with reference to aetiology, time of survival and role of immunological processes. (1973) (3)
- Hepatocyte growth factor and plasminogen activation in fulminant hepatic failure. (1994) (3)
- TREATMENT OF ACETAMINOPHEN-INDUCED HEPATITIS AND FULMINANT HEPATIC FAILURE BY THE BIOLOGIC-DT SYSTEM (1999) (3)
- Further experience of late onset hepatic failure. (1993) (2)
- Hepatic scintiscanning in fulminant hepatic failure. (1973) (2)
- Controlled Hyperventilation in the Management of Cerebral Oedema in Fulminant Hepatic Failure (1985) (2)
- High plasma endothelin in hepatorenal syndrome (1991) (2)
- Effects of intraportal prostacyclin on hepatic bile flow in the rat. (1986) (2)
- The value of scintiscanning in the diagnosis of hepatic tumours using both selenomethionine and technetium. (1970) (2)
- Altered Plasma and Platelet Lipids and Their Effect on Platelet Function in Fulminant Hepatic Failure (1984) (2)
- BIOLOGIC-DT SYSTEM IN TREATMENT OF ACUTE HEPATIC COMA; RESULTS OF RANDOMIZED, CONTROLLED TRIALS (1996) (2)
- Proceedings: Disturbed brain tryptophan metabolism in fulminant hepatic failure. (1975) (1)
- Blood Brain Barrier Permeability in Acute Hepatic Failure: Studies in Two Animal Models (1984) (1)
- Molecular Adsorbents Recirculating System: Early clinical experience. (2001) (1)
- Dimethylarginine (nos inhibitor) levels predict in-patient mortality in alcoholic hepatitis (2005) (1)
- Selection of an Adsorbent and Hemoperfusion Column Design (1981) (1)
- Inhibition of Rat Brain Na+, K+-ATPase by Serum from Patients with Fulminant Hepatic Failure and the Removal of Inhibitors by Haemoperfusion (1984) (1)
- ELEVATED PLASMA CARNITINE CONTENT IN ACUTE (PARACETAMOL-INDUCED) LIVER DAMAGE IN HUMANS (1991) (1)
- Proceedings: Fulminant hepatic failure: histological quantitation of surviving liver parenchyma in the evaluation of the cause of death. (1974) (1)
- Low myo-inositol and high glutamine levels in the brain are associated with neuropsychological deterioration following induced hyperammonemia (2004) (1)
- Pathophysiological basis of clinical changes following treatment with MARS in acute-on-chronic liver failure: A randomized evaluation (2002) (1)
- THE ROLE OF DDAH-ADMA IN THE REGULATION OF HEPATIC ENOS ACTIVITY IN ACUTE AND CHRONIC LIVER FAILURE (2008) (1)
- Nutrition and the liver and pancreas (1986) (1)
- New view on treatment of portal hypertension. (1978) (1)
- Intestinal permeability in critical illness and acute liver failure: The relationship with severity of illness, spalanchnic ischemia and survival (1998) (0)
- It is justified to biopsy presumed hepatocellular carcinoma (HCC) when the alfa fetoprotein (AFP) is normal. (2001) (0)
- P.44 Glycogen degradation during acute liver disease and following orthotopic liver transplantation (1997) (0)
- Tumor necrosis factor in tulminant hepatic failure (1990) (0)
- Oxygen consumption and mitochondrial function by the brain is severely perturbed during the early phase of liver failure. (2004) (0)
- Acute Liver Failure: An Overview (1989) (0)
- Fibronectin and liver disease. (1987) (0)
- [212] BRAIN SWELLING AND COMA IN CIRRHOTIC RATS ADMINISTERED ENDOTOXIN IS ASSOCIATED WITH INCREASED PROTEIN NITROSATION (2007) (0)
- Hepatic inflammation is an important determinant of portal pressure in alcoholic liver disease (2003) (0)
- Hepatic Encephalopathy: A multiorgan perspective. (2003) (0)
- P.138 Small bowel and colonic permeability in generalICU and acute liver failure patients: association with endotoxaemia (1998) (0)
- Gastrointestinal hormonal changes of acute hepatic failure in the pig. (1981) (0)
- Endotoxemia and its association with colonic and small bowel permeability in acute liver failure and patients on a general ICU (1998) (0)
- O.63 Intestinal permeability in acute liver failure: relationshipwith severity of illness, splanchnic ischaemia and endotoxaemia (1998) (0)
- Inhibition of bile secretion in the rat by serum ultrafiltrates and fractions from patients with fulminant hepatic failure. (1988) (0)
- In Vivo Reduction of Na+, K+-ATPase Activity in Rat Brain during D-Galactosamine-Induced Acute Hepatic Failure: A Possible Cause of Encephalopathy (1984) (0)
- Inflammation significantly exacerbates the effect of hyperammonemia on neurological function in cirrhosis (2003) (0)
- Effects of eicosanoids secreted by stimulated Kupffer cells on isolated rat hepatocytes. (1997) (0)
- The novel gene nostrin and a splice-variant are highly expressed in alcoholic hepatitis and may explain increased intra-hepatic resistance despite normal eNOS expression (2004) (0)
- Is spontaneous bacterial peritonitis, spontaneous? (1991) (0)
- PROTHROMBIN TIME AND PARACETAMOL-INDUCED FULMINANT HEPATIC FAILURE (1991) (0)
- The cost of variceal bleeding in cirrhosis: A pharmacoeconomic model of the UK variceal haemorrhage guidelines (2003) (0)
- Remote ischaemic preconditioning of the hind limb reduces the local and systemic adverse effects of reperfusion injury following total liver ischaemia (2004) (0)
- Piroxicam-induced subacute hepatic necrosis. (1986) (0)
- Remote ischaemic preconditioning of the hind limb improves systemic haemodynamics and reduces reperfusion injury to the liver and lung (2003) (0)
- Selected Commentary to: "Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study" (2005) (0)
- Worsening of cerebral hyperaemia in acute liver failure (ALF) with terlipressin (2003) (0)
- Encephalopathy Associated with Liver Disease (1989) (0)
- Oxidant stress in the pathogenesis of the hepatorenal syndrome (1993) (0)
- Treatment with anti-tumour necrosis factor a (TNF alpha) antibody improves clinical parameters and lowers portal pressure in alcoholic hepatitis (2003) (0)
- Factor Viii Complex in Fulminant Hepatic Failure (1984) (0)
- Experimental Studies of Blood-Brain Barrier Permeability in Chronic Hepatic Encephalopathy (1984) (0)
- RECENT ADVANCES IN CLINICAL PRACTICE PROSPECTS FOR EXTRACORPOREAL LIVER SUPPORT (2004) (0)
- O.19Intestinal permeability in critical illness: relationshipwith severity of illness, splanchnic ischaemia and endotoxaemia (1998) (0)
- Improvement in portal and regional haemodynamics following anti-TNF therapy in alcoholic hepatitis (2003) (0)
- Fulminant hepatic failure and artificial liver support. (1985) (0)
- Selective digestive decontamination during acute hepatic failure (1992) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With R. W. Williams?
R. W. Williams is affiliated with the following schools: